Fabry Disease Screening in ESRD Patients in West of France

N/ACompletedNCT02719249

Rennes University Hospital500 enrolled

Overview

Screening of Fabry disease in end-stage renal disease (ESRD) patients on dialysis or transplant in west of France.

Detection of Fabry disease is done by dried blood spot test, in dialyzed and transplanted men, who reached ESRD for vascular or unknown disease and were not previously screened.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

ESRD

Interventions

Dried blood spot testOTHER

Eligibility

Sex: MALEMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Men less than 70 years old * ESRD treated by dialysis or kidney graft in one of the 4 following regions : Bretagne, Centre, Pays de la Loire and Poitou-Charentes * For unknown nephropathy OR vascular nephropathy and/or diabetic nephropathy unproved by biopsy * Agreeing freely to participate in the study Exclusion Criteria: * Men less than 18 years old * Persons subject to major legal protection (safeguarding justice, guardianship, trusteeship), persons deprived of liberty.

Locations (1)

CHU de Rennes

Rennes, France

Outcomes

Primary Outcomes

To detect Fabry disease by dried blood spot test, in dialyzed and transplanted men, who reached ESRD for vascular or unknown disease and were not previously screened

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.